FDA Approves 200th Antiretroviral Drug Application
FDA: PEPFAR: FDA Approves 200th HIV/AIDS Therapy
Scott Gottlieb, commissioner of the U.S. Food and Drug Administration, discusses the approval of the 200th antiretroviral drug application as well as FDA’s work with PEPFAR to develop HIV therapies and provide access to HIV treatment (12/1).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.